SIRT1 and diabetes mellitus: SRT2104 (Figure 1) is a novel, highly selective small-molecule SIRT1 activator (Hoffmann et al., 2013), which can improve DM-induced aortic endothelial dysfunction in mice and have a protective effect on DN (Brooks et al., 2003; Wu et al., 2018).